1. Home
  2. INDP vs ISPO Comparison

INDP vs ISPO Comparison

Compare INDP & ISPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • ISPO
  • Stock Information
  • Founded
  • INDP 2000
  • ISPO 2010
  • Country
  • INDP United States
  • ISPO United States
  • Employees
  • INDP N/A
  • ISPO N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • ISPO Blank Checks
  • Sector
  • INDP Health Care
  • ISPO Finance
  • Exchange
  • INDP Nasdaq
  • ISPO Nasdaq
  • Market Cap
  • INDP 15.4M
  • ISPO 13.4M
  • IPO Year
  • INDP N/A
  • ISPO N/A
  • Fundamental
  • Price
  • INDP $1.16
  • ISPO $3.85
  • Analyst Decision
  • INDP Strong Buy
  • ISPO Buy
  • Analyst Count
  • INDP 1
  • ISPO 2
  • Target Price
  • INDP $12.00
  • ISPO $10.50
  • AVG Volume (30 Days)
  • INDP 21.1K
  • ISPO 35.6K
  • Earning Date
  • INDP 11-04-2024
  • ISPO 11-04-2024
  • Dividend Yield
  • INDP N/A
  • ISPO N/A
  • EPS Growth
  • INDP N/A
  • ISPO N/A
  • EPS
  • INDP N/A
  • ISPO N/A
  • Revenue
  • INDP N/A
  • ISPO $300,935,000.00
  • Revenue This Year
  • INDP N/A
  • ISPO N/A
  • Revenue Next Year
  • INDP N/A
  • ISPO N/A
  • P/E Ratio
  • INDP N/A
  • ISPO N/A
  • Revenue Growth
  • INDP N/A
  • ISPO N/A
  • 52 Week Low
  • INDP $1.03
  • ISPO $3.11
  • 52 Week High
  • INDP $3.25
  • ISPO $9.98
  • Technical
  • Relative Strength Index (RSI)
  • INDP 36.05
  • ISPO 43.72
  • Support Level
  • INDP $1.11
  • ISPO $3.65
  • Resistance Level
  • INDP $1.27
  • ISPO $4.07
  • Average True Range (ATR)
  • INDP 0.13
  • ISPO 0.30
  • MACD
  • INDP -0.00
  • ISPO -0.06
  • Stochastic Oscillator
  • INDP 22.03
  • ISPO 16.20

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About ISPO Inspirato Incorporated

Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.

Share on Social Networks: